| Date | Time | Source | Headline | Symbol | Company |
| 11/08/2011 | 8:00AM | Marketwired | AVI BioPharma to Present Company Overview at the Lazard Capital Markets 8th Annual Healthcare Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/03/2011 | 4:25PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/03/2011 | 4:05PM | Marketwired | AVI BioPharma Announces Third Quarter 2011 Financial Results and Recent Corporate Developments | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/26/2011 | 8:00AM | Marketwired | AVI BioPharma Announces Third Quarter 2011 Financial Results and Corporate Update Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/21/2011 | 8:16AM | Marketwired | Volatility Grows in Biotech Sector -- Keryx and AVI BioPharma Need to Put Up Results | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/21/2011 | 8:00AM | Marketwired | AVI BioPharma's RNA-Based Therapeutics for Treatment of Ebola and Marburg Viruses Show Positive Safety Data in First Five of ... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/18/2011 | 8:00AM | Marketwired | AVI BioPharma Announces Data Presentation for RNA-Based Duchenne Muscular Dystrophy Drug Candidate at the 16th International ... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/14/2011 | 8:30AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/29/2011 | 4:31PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/19/2011 | 3:51PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/19/2011 | 8:00AM | Marketwired | AVI BioPharma Announces Presentations at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/14/2011 | 5:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/14/2011 | 8:00AM | Marketwired | AVI BioPharma to Present Company Overview at the UBS Global Life Sciences Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/07/2011 | 8:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/06/2011 | 4:56PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/06/2011 | 8:16AM | Marketwired | AEterna Zentaris and AVI BioPharma Maintain Steady Pipelines | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/06/2011 | 6:21AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/02/2011 | 8:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/02/2011 | 8:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/02/2011 | 8:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 09/01/2011 | 8:00AM | Marketwired | AVI BioPharma to Present Company Overview at the Stifel Nicolaus 2011 Healthcare Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/29/2011 | 4:58PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/15/2011 | 4:05PM | Marketwired | AVI BioPharma Initiates Dosing in Phase 2 Study of Eteplirsen in Duchenne Muscular Dystrophy Patients | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/10/2011 | 8:00AM | Marketwired | AVI BioPharma to Present Company Overview at the Wedbush Securities Life Science Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/08/2011 | 5:12PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/08/2011 | 4:14AM | Zacks | Zacks #1 Rank Additions for Monday - Tale of the Tape | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 08/04/2011 | 4:00PM | Marketwired | AVI BioPharma Announces Second Quarter 2011 Financial Results and Recent Corporate Developments | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/29/2011 | 5:19PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/28/2011 | 8:00AM | Marketwired | AVI BioPharma Announces Second Quarter 2011 Financial Results and Corporate Update Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/25/2011 | 7:00AM | Marketwired | The Lancet Publishes Clinical Trial Data That Demonstrate Statistically Significant and Dose-Dependent Expression of Dystrophin | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |